Insider Trading

Notable insider buying and selling activity across public companies.

Tracking and analysis of reported insider transactions, including executive and director buying or selling. Insider activity can offer insight into internal confidence, valuation perceptions, and potential inflection points.

Articles

10,018 total articles

Insider Activity at Streamex Corp Signals Potential Internal Confidence Amid Financial Transition

Insider Activity at Streamex Corp Signals Potential Internal Confidence Amid Financial Transition

Morgan Lekstrom, Interim Executive Chairman of Streamex Corp., recently acquired a significant block of the company's common stock. This insider buying occurs while the stock trades near its 52-week lows, following recent quarterly earnings that missed analyst forecasts. The transactions highlight internal interest amid the firm's ongoing effort to…

Executive Selling Activity at Venture Global Signals Market Valuation Concerns Amid Strong Fundamentals

Executive Selling Activity at Venture Global Signals Market Valuation Concerns Amid Strong Fundamentals

Venture Global's Chief Operating Officer, Brian Cothran, executed multiple transactions between May 19 and May 21, 2026, selling approximately $9.2 million worth of company shares. These sales followed the exercise of stock options for a total acquisition value of $726,236. The activity took place while Venture Global (NASDAQ: VG) shares maintain h…

Executive Chairman Ernest Rady Increases Stake in American Assets Trust Through Open Market Purchases

Executive Chairman Ernest Rady Increases Stake in American Assets Trust Through Open Market Purchases

Ernest S. Rady, Executive Chairman of American Assets Trust, Inc. (NYSE:AAT), recently executed several open market purchases totaling approximately $1.7 million in the company's common stock over a three-day period in May 2026. These transactions occurred while AAT shares were trading near their 52-week high. The filing details specific acquisitio…

Director's Purchase of Stock at Entrada Therapeutics Signals Internal Confidence Amid Clinical Milestones

Director's Purchase of Stock at Entrada Therapeutics Signals Internal Confidence Amid Clinical Milestones

A significant transaction involving a director at Entrada Therapeutics, Inc. (NASDAQ:TRDA) suggests internal belief in the company's valuation as the firm prepares to announce key clinical data. Bernhardt G. Zeiher purchased 5,000 shares of common stock on May 20, 2026, at prices ranging from $5.86 to $6.00 per share. This buying activity occurs wh…

Quicklogic CEO Sells Shares Following Stock Option Exercise

Quicklogic CEO Sells Shares Following Stock Option Exercise

The Chief Executive Officer of QUICKLOGIC Corp, Brian C. Faith, recently sold a substantial amount of the company's common stock following the exercise of fully vested options. This transaction occurred as Quicklogic reported its first-quarter 2026 earnings, which showed mixed results, alongside securing a new $2.7 million contract for FPGA design.